You must log in to view this page.

NRX Pharmaceuticals Inc.

NASDAQ: NRXP
Share price (10/21/25): $3.21
Market cap (10/21/25): $63.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

Late quarterly filing notification for Q2 2025

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration withdrawal request

Shelf registration

Prospectus supplement

Exempt offering of securities

Ownership Filter

Javitt Jonathan C

Flynn Patrick John

News Filter

Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Selected to Present at the 2025 Global Passion Project With Matthew Rockefeller and Rockefeller Capital

Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients With Depression, Including Bipolar Depression

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness